Manostaxx at CPhI 2022 Frankfurt with SOMAI Pharmaceuticals

Manostaxx was at CPhI 2022 at Frankfurt with Somai Pharmaceuticals.

Michael Sassano, Founder, Chairman & CEO Somai Pharmaceuticals and Investor, Cannabis, GMP, Pharmaceutical &Herbal Medicine was present with George Bellow, Chief Operating Officer / CO-Founder at SOMAÍ Pharmaceuticals and Vasiliki Koutelieri,  Country Director.

The Stand was full with meetings with Companies representatives:

Somai Pharmaceuticals is developing 41 products, some shown in the expositor:


Visit Somai Pharmaceuticals site:   Somai Pharmaceuticals




Leave a Reply

Your email address will not be published. Required fields are marked *